M
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Matthew Plotkin's research investigates the molecular mechanisms underlying drug-induced cardiotoxicity, particularly in the context of cancer treatment. His work has focused on identifying predictive biomarkers for early detection of this adverse effect. A recent publication in 2021 explored genome-wide DNA methylation signatures as predictors of asymptomatic doxorubicin-induced cardiotoxicity in breast cancer patients.
Plotkin's scholarly contributions include 27 publications, with a total of 1,961 citations, and an h-index of 16. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Michael Bauer, Jeanne Y. Wei, and Ping-Ching Hsu, on shared publications.
Metrics
- h-index: 16
- Publications: 27
- Citations: 1,965
Selected Publications
-
Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer (2021)
Collaboration Network
Top Collaborators
Michael Bauer
University of Arkansas for Medical Sciences
1 shared publication
In database
- Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer
Валентина Тодорова
University of Arkansas for Medical Sciences (US)
1 shared publication
- Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer
Annjanette Stone
Central Arkansas Veterans Healthcare System (US)
1 shared publication
- Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer
Weleetka Carter
Central Arkansas Veterans Healthcare System (US)
1 shared publication
- Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer
Ping-Ching Hsu
University of Arkansas for Medical Sciences
1 shared publication
In database
- Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer
Jeanne Y. Wei
University of Arkansas for Medical Sciences
1 shared publication
In database
- Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer
Joseph Su
University of Arkansas for Medical Sciences (US)
1 shared publication
- Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer
Issam Makhoul
University of Arkansas for Medical Sciences (US)
1 shared publication
- Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer
Similar Researchers
Based on overlapping research topics
David P. Douglass
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Cardiovascular Function and Risk Factors
Jim Zhongning Chen
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Epigenetics and DNA Methylation
Cardiovascular Function and Risk Factors
Kimo C. Stine
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Cardiovascular Function and Risk Factors
Valentina K. Todorova
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Cardiovascular Function and Risk Factors
Leah Brazil
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Cardiovascular Function and Risk Factors
Tra Le
Arkansas State University
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research